Gladstone Institute of Neurological Disease Celebrates 20 Years at the Forefront of Disease-Focused Neuroscience
Learn about the institute’s foundational discoveries and current research efforts in the latest scientific report Click Here
MS News Today – National MS Society Invests in Clinical Development of Human Antibody for Progressive Forms of MS
October 31, 2018
Click Here to read full news article.
New Immunotherapy Targeting Blood-Clotting Protein Protects MS and AD, Published in Nat Immunol 2018
Akassoglou Lab Marks Its 10th Year at Gladstone Institutes
On April 1, 2018, Katerina Akassoglou celebrated the 10th anniversary of her lab at Gladstone. She and her team have made great strides in advancing our understanding of neurological diseases and identifying potential therapeutic targets.
Katerina Akassoglou elected to the Annals of Neurology Editorial Board
Katerina Akassoglou was elected to the editorial board of the Annals of Neurology, the official journal of the American Association of Neurology. Her 3- year term wil. start January 2018.
